These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12706048)

  • 1. Polyhydroxyalkanonate derivatives in current clinical applications and trials.
    Ueda H; Tabata Y
    Adv Drug Deliv Rev; 2003 Apr; 55(4):501-18. PubMed ID: 12706048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(epsilon-caprolactone) and poly (L-lactic-co-glycolic acid) degradable polymer sponges attenuate astrocyte response and lesion growth in acute traumatic brain injury.
    Wong DY; Hollister SJ; Krebsbach PH; Nosrat C
    Tissue Eng; 2007 Oct; 13(10):2515-23. PubMed ID: 17655492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the development of bioresorbable polymers for medical applications.
    Pulapura S; Kohn J
    J Biomater Appl; 1992 Jan; 6(3):216-50. PubMed ID: 1573554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering.
    Jeong B; Lee KM; Gutowska A; An YH
    Biomacromolecules; 2002; 3(4):865-8. PubMed ID: 12099835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of material properties of biodegradable and bioresorbable polymers and devices for GTR and GBR applications.
    Hutmacher D; Hürzeler MB; Schliephake H
    Int J Oral Maxillofac Implants; 1996; 11(5):667-78. PubMed ID: 8908867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in biodegradable synthetic polymers.
    Gunatillake P; Mayadunne R; Adhikari R
    Biotechnol Annu Rev; 2006; 12():301-47. PubMed ID: 17045198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the cross-linking enzyme tissue transglutaminase in the biological recognition of synthetic biodegradable polymers.
    Verderio E; Coombes A; Jones RA; Li X; Heath D; Downes S; Griffin M
    J Biomed Mater Res; 2001 Feb; 54(2):294-304. PubMed ID: 11093190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(hydroxy acids) in drug delivery.
    Juni K; Nakano M
    Crit Rev Ther Drug Carrier Syst; 1987; 3(3):209-32. PubMed ID: 3549007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of viscous and injectable poly(ortho esters).
    Einmahl S; Capancioni S; Schwach-Abdellaoui K; Moeller M; Behar-Cohen F; Gurny R
    Adv Drug Deliv Rev; 2001 Dec; 53(1):45-73. PubMed ID: 11733117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved biocompatibility of poly(lactic-co-glycolic acid) orv and poly-L-lactic acid blended with nanoparticulate amorphous calcium phosphate in vascular stent applications.
    Zheng X; Wang Y; Lan Z; Lyu Y; Feng G; Zhang Y; Tagusari S; Kislauskis E; Robich MP; McCarthy S; Sellke FW; Laham R; Jiang X; Gu WW; Wu T
    J Biomed Nanotechnol; 2014 Jun; 10(6):900-10. PubMed ID: 24749387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication strategies and potential applications of the "green" microstructured optical fibers.
    Dupuis A; Guo N; Gao Y; Skorobogata O; Gauvreau B; Dubois C; Skorobogatiy M
    J Biomed Opt; 2008; 13(5):054003. PubMed ID: 19021383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly-L-lactic acid: a temporary filler for soft tissue augmentation.
    Woerle B; Hanke CW; Sattler G
    J Drugs Dermatol; 2004; 3(4):385-9. PubMed ID: 15303782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polymers for ocular drug delivery.
    Kimura H; Ogura Y
    Ophthalmologica; 2001; 215(3):143-55. PubMed ID: 11340382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue engineering: a new take-off using nanofiber-based scaffolds.
    Ashammakhi N; Ndreu A; Yang Y; Ylikauppila H; Nikkola L; Hasirci V
    J Craniofac Surg; 2007 Jan; 18(1):3-17. PubMed ID: 17251828
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release.
    Takenaga M; Yamaguchi Y; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Control Release; 2002 Feb; 79(1-3):81-91. PubMed ID: 11853920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-L-lactic acid: an overview.
    Simamora P; Chern W
    J Drugs Dermatol; 2006 May; 5(5):436-40. PubMed ID: 16703779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastic biodegradable poly(glycolide-co-caprolactone) scaffold for tissue engineering.
    Lee SH; Kim BS; Kim SH; Choi SW; Jeong SI; Kwon IK; Kang SW; Nikolovski J; Mooney DJ; Han YK; Kim YH
    J Biomed Mater Res A; 2003 Jul; 66(1):29-37. PubMed ID: 12833428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations for the use of injectable poly-L-lactic acid in people of color.
    Hamilton TK; Burgess CM
    J Drugs Dermatol; 2010 May; 9(5):451-6. PubMed ID: 20480787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An introduction to biodegradable materials for tissue engineering applications.
    Hutmacher DW; Goh JC; Teoh SH
    Ann Acad Med Singap; 2001 Mar; 30(2):183-91. PubMed ID: 11379417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactic acid) blends in biomedical applications.
    Saini P; Arora M; Kumar MNVR
    Adv Drug Deliv Rev; 2016 Dec; 107():47-59. PubMed ID: 27374458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.